Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Extrawell Pharmaceutical Holdings Limited 0858.HK
$0.06
+$0 (5.00%)
На 18:03, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
141010008.00000000
-
week52high
0.12
-
week52low
0.06
-
Revenue
73925000
-
P/E TTM
1
-
Beta
0.52938900
-
EPS
0.03000000
-
Last Dividend
0.00000000
-
Next Earnings Date
29 ноя 2022 г. в 11:51
Описание компании
Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People's Republic of China. The company operates through Manufacturing, Trading, and Gene Development segments. It offers transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus infection and weak cellular immune system; and Wisk for the treatment of II-III degree of radio-injury of skin, normal common burn, actinic dermatitis, various infectious ulcers, and oral ulcers, as well as for trauma and post operation wound healing. The company also provides ZhouBang, a thromboxane synthetase inhibitor to prevent the coagulation of platelets and facilitate relaxation of blood vessels. In addition, it is involved in the marketing and distribution of imported pharmaceutical products, including Millibar for the treatment of high blood pressure; and development of oral insulin. Further, the company engages in the commercial exploitation and development of genome-related technology; provision of agency services; property investment business; and holding of gene invention rights. Extrawell Pharmaceutical Holdings Limited is headquartered in Quarry Bay, Hong Kong.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии